The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II)
- 1 November 2018
- journal article
- research article
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 23 (1) , 27-51
Abstract
The present era of precision medicine sees “cancer” as a consequence of molecular derangements occurring at the commencement of the disease process, with morphological changes happening much later in the process of tumourigenesis. Conventional imaging techniques, such as computed tomography (CT), ultrasound (US) and magnetic resonance imaging (MRI) play an integral role in the detection of disease at the macroscopic level. However, molecular functional imaging (MFI) techniques entail the visualisation and quantification of biochemical and physiological processes occurring during tumourigenesis. MFI has the potential to play a key role in heralding the transition from the concept of “one-size-fits-all” treatment to “precision medicine”. Integration of MFI with other fields of tumour biology such as genomics has spawned a novel concept called “radiogenomics”, which could serve as an indispensable tool in translational cancer research. With recent advances in medical image processing, such as texture analysis, deep learning and artificial intelligence, the future seems promising; however, their clinical utility remains unproven at present. Despite the emergence of novel imaging biomarkers, the majority of these require validation before clinical translation is possible. In this two part review, we discuss the systematic collaboration across structural, anatomical and molecular imaging techniques that constitute MFI. Part I reviews positron emission tomography, radiogenomics, AI, and optical imaging, while part II reviews MRI, CT and ultrasound, their current status, and recent advances in the field of precision oncology.Keywords
This publication has 137 references indexed in Scilit:
- Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Insights into Imaging, 2012
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migrationNeuroImage, 2012
- Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastomaNeuroImage, 2012
- Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomasEuropean Journal of Cancer, 2011
- Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptidesNature Medicine, 2010
- Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1‐13C]pyruvate and 13C magnetic resonance spectroscopic imagingMagnetic Resonance in Medicine, 2010
- Ferritin as a reporter gene for MRI: chronic liver over expression of h‐ferritin during dietary iron supplementation and agingNMR in Biomedicine, 2010
- MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrastNeuroImage, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009